1 Min Read
Aug 11 (Reuters) - Bayer AG : * Says receives EU approval for Eylea in diabetic macular edema * Says plans for an immediate roll-out with Germany being one of the first
launch countries in Europe
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.